feed,title,long_url,short_url
PubMed,[Vaccine] One-year follow-up of the immunogenicity and safety of a first and second booster dose of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Final report of a phase 3 open-label trial,https://pubmed.ncbi.nlm.nih.gov/40753673,
